Coronary heart disease is an important source of mortality and morbidity among kidney
transplantation and liver transplantation candidates and recipients and is driven by …

Nonalcoholic steatohepatitis (NASH)-related cirrhosis has become one of the most common
indications for liver transplantation (LT), particularly in candidates older than 65 years …

Liver transplant (LT) candidates today are older, have greater medical severity of illness,
and have more cardiovascular comorbidities than ever before. In addition, there are specific …

In the changing landscape of liver transplantation (LT), we are now evaluating older and
sicker patients with more cardiovascular comorbidities, and the spectrum of cardiovascular …

Summary Liver transplant (ation)(LT) is the most effective treatment for patients with
decompensated liver disease. The increasing prevalence of obesity and type 2 diabetes and …

Improvements in the management of patients undergoing liver transplantation (LT) have
resulted in a significant increase in survival in recent years. Cardiac disease is now the …

Cardiovascular events have a major impact on overall outcomes after liver transplantation.
Today's transplant patients are older than those in the past and therefore are more likely to …

Despite the slowly progressive nature of NAFLD, the number of patients with NAFLD-related
cirrhosis significantly increased. Although the management of patients with cirrhosis …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide.
Patients with NAFLD are at a higher risk of developing cardiovascular disease (CVD). In fact …

Background & Aims Patients with cirrhosis and significant coronary artery disease (CAD) are
at risk of peri-liver transplantation (LT) cardiac events. The coronary artery disease in liver …